
Metabolic · research grade
CJC-1295 / Ipamorelin
Two-peptide blend: CJC-1295 (no DAC) and Ipamorelin. Independently verified and released in the United States.
A co-lyophilized blend of two growth-hormone secretagogues with different mechanisms. CJC-1295 is a GHRH(1-29) analog whose albumin-binding modification extends its half-life to days.Source 1,Source 2 Ipamorelin is a pentapeptide agonist at the ghrelin receptor, described on publication as the first selective growth hormone secretagogue.Source 3 The literature cited is for the two peptides studied separately; no published study has evaluated this combination.